TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6021
+0.0418 (7.46%)
At close: Apr 14, 2026, 4:00 PM EDT
0.60095
-0.0011 (-0.18%)
After-hours: Apr 14, 2026, 4:00 PM EDT
TELA Bio Stock Forecast
Stock Price Forecast
The 4 analysts that cover TELA Bio stock have a consensus rating of "Strong Buy" and an average price target of $2.00, which forecasts a 232.17% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $3.00.
Price Target: $2.00 (+232.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TELA Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $5 → $3 | Buy | Maintains | $5 → $3 | +398.26% | Mar 27, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1 | Hold | Maintains | $1.25 → $1 | +66.09% | Mar 25, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +232.17% | Mar 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $4 → $2 | Strong Buy | Maintains | $4 → $2 | +232.17% | Mar 25, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +398.26% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
88.48M
from 80.28M
Increased by 10.23%
Revenue Next Year
101.10M
from 88.48M
Increased by 14.26%
EPS This Year
-0.69
from -0.83
EPS Next Year
-0.52
from -0.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 91.4M | 112.2M | |
| Avg | 88.5M | 101.1M | |
| Low | 84.6M | 93.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.8% | 26.7% | |
| Avg | 10.2% | 14.3% | |
| Low | 5.4% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.60 | -0.27 | |
| Avg | -0.69 | -0.52 | |
| Low | -0.86 | -0.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.